Antibacterial activity of xylose-derived LpxC inhibitors - Synthesis, biological evaluation and molecular docking studies.
Name:
Publisher version
View Source
Access full-text PDFOpen Access
View Source
Check access options
Check access options
Average rating
Cast your vote
You can rate an item by clicking the amount of stars they wish to award to this item.
When enough users have cast their vote on this item, the average rating will also be shown.
Star rating
Your vote was cast
Thank you for your feedback
Thank you for your feedback
Authors
Dreger, AlexanderHoff, Katharina
Agoglitta, Oriana
Hotop, Sven-Kevin
Brönstrup, Mark

Heisig, Peter
Kirchmair, Johannes
Holl, Ralph
Issue Date
2020-12-31
Metadata
Show full item recordAbstract
LpxC inhibitors represent a promising class of novel antibiotics selectively combating Gram-negative bacteria. In chiral pool syntheses starting from D- and L-xylose, a series of four 2r,3c,4t-configured C-furanosidic LpxC inhibitors was obtained. The synthesized hydroxamic acids were tested for antibacterial and LpxC inhibitory activity, the acquired biological data were compared with those of previously synthesized C-furanosides, and molecular docking studies were performed to rationalize the observed structure-activity relationships. Additionally, bacterial uptake and susceptibility to efflux pump systems were investigated for the most promising stereoisomers.Citation
Bioorg Chem. 2020 Dec 31;107:104603. doi: 10.1016/j.bioorg.2020.104603. Epub ahead of print.Affiliation
HZI,Helmholtz-Zentrum für Infektionsforschung GmbH, Inhoffenstr. 7,38124 Braunschweig, Germany.Publisher
ElsevierJournal
Bioorganic chemistryPubMed ID
33429229Type
ArticleLanguage
enEISSN
1090-2120ae974a485f413a2113503eed53cd6c53
10.1016/j.bioorg.2020.104603
Scopus Count
The following license files are associated with this item:
- Creative Commons
Except where otherwise noted, this item's license is described as Attribution-NonCommercial-NoDerivatives 4.0 International
Related articles
- Synthesis, biological evaluation, and molecular docking studies of deoxygenated C-glycosides as LpxC inhibitors.
- Authors: Dreger A, Hoff K, Agoglitta O, Bülbül EF, Melesina J, Sippl W, Holl R
- Issue date: 2021 Dec
- Chiral Pool Synthesis, Biological Evaluation and Molecular Docking Studies of C-Furanosidic LpxC Inhibitors.
- Authors: Dreger A, Kharwb O, Agoglitta O, Bülbül EF, Melesina J, Sippl W, Holl R
- Issue date: 2019 Apr 17
- Synthesis, biological evaluation, and molecular docking studies of aldotetronic acid-based LpxC inhibitors.
- Authors: Wimmer S, Hoff K, Martin B, Grewer M, Denni L, Lascorz Massanet R, Raimondi MV, Bülbül EF, Melesina J, Hotop SK, Haupenthal J, Rohde H, Heisig P, Hirsch AKH, Brönstrup M, Sippl W, Holl R
- Issue date: 2023 Feb
- Chiral pool synthesis and biological evaluation of C-furanosidic and acyclic LpxC inhibitors.
- Authors: Müller H, Gabrielli V, Agoglitta O, Holl R
- Issue date: 2016 Mar 3
- Synthesis, biological evaluation and molecular docking studies of benzyloxyacetohydroxamic acids as LpxC inhibitors.
- Authors: Szermerski M, Melesina J, Wichapong K, Löppenberg M, Jose J, Sippl W, Holl R
- Issue date: 2014 Feb 1